Arlen Meyers, MD, MBA Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

 

How to Create Clinical Translational Science Entrepreneurs

Under NCATS’ leadership, the Clinical and Translational Science Awards (CTSA) Program supports a national network of medical research institutions — called hubs ― that work together to improve the translational research process to get more treatments to more patients more quickly. The hubs collaborate locally and regionally to catalyze innovation in training, research tools and processes.

Read More...

Digital Health Therapeutics Issues and Opportunities

Digital health refers to using information and communications technologies to send or receive medical information. Some provide information and education while others have the intended use of diagnosing or treating a patient with symptoms or a disease. In the latter case, they can be considered a medical device , and, as such, what is more commonly being referred to as a digital therapeutic (DTx).

Read More...

How About Doctor Consumerism?

The latest sick care-ism is medical consumerism. This latest affront to the profession—one that affects medical insurers as well—comes as a direct result of the national effort to encourage people to take greater control of their medical care. Obamacare made citizens aware that they had choices and challenged them to educate themselves. Suddenly, yesterday’s patient became tomorrow’s potential customer.

Read More...

The Conventional Wisdom is Fake News

If anything else, the role of innovators is to challenge the conventional wisdom. But, blowing things up, poking your fingers in the eyes of vested interests and ignoring conventional wisdom often come with serious consequences.

Read More...

Get it Right, Not in Writing

We've all heard the advice that entrepreneurs should get EVERYTHING in writing.

Read More...
Save
Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Analytics
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics
Accept
Decline